- Home
- AMKR vs AXSM Comparison
AMKR vs AXSM Comparison
Compare AMKR & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMKR
- AXSM
- Stock Information
- Founded
- AMKR 1968
- AXSM 2012
- Country
- AMKR United States
- AXSM United States
- Employees
- AMKR N/A
- AXSM N/A
- Industry
- AMKR Semiconductors
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- AMKR Technology
- AXSM Health Care
- Exchange
- AMKR Nasdaq
- AXSM Nasdaq
- Market Cap
- AMKR 6.1B
- AXSM 5.1B
- IPO Year
- AMKR 1998
- AXSM 2015
- Fundamental
- Price
- AMKR $19.92
- AXSM $107.22
- Analyst Decision
- AMKR Buy
- AXSM Strong Buy
- Analyst Count
- AMKR 7
- AXSM 15
- Target Price
- AMKR $26.67
- AXSM $170.20
- AVG Volume (30 Days)
- AMKR 2.1M
- AXSM 650.4K
- Earning Date
- AMKR 04-28-2025
- AXSM 05-05-2025
- Dividend Yield
- AMKR 3.68%
- AXSM N/A
- EPS Growth
- AMKR N/A
- AXSM N/A
- EPS
- AMKR 1.28
- AXSM N/A
- Revenue
- AMKR $6,273,756,000.00
- AXSM $432,157,000.00
- Revenue This Year
- AMKR $1.79
- AXSM $62.62
- Revenue Next Year
- AMKR $6.24
- AXSM $62.94
- P/E Ratio
- AMKR $15.46
- AXSM N/A
- Revenue Growth
- AMKR N/A
- AXSM 72.16
- 52 Week Low
- AMKR $14.03
- AXSM $64.11
- 52 Week High
- AMKR $44.86
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- AMKR 64.64
- AXSM 47.24
- Support Level
- AMKR $17.18
- AXSM $103.02
- Resistance Level
- AMKR $20.28
- AXSM $110.95
- Average True Range (ATR)
- AMKR 0.58
- AXSM 4.11
- MACD
- AMKR 0.39
- AXSM -0.17
- Stochastic Oscillator
- AMKR 90.37
- AXSM 24.74
About AMKR Amkor Technology Inc.
Amkor Technology Inc is a provider of outsourced semiconductor packaging and test services to integrated device manufacturers, fabless semiconductor companies, and contract foundries. The firm's products are organized into two categories namely advanced products that include flip chip, fine pitch bumping, wafer-level processing, advanced SiPs, power modules, and others, and Mainstream products that includes wirebond packaging and testing. The company derives maximum revenue from the advanced products category. The company derives majority of its revenue from Foreign states.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.